Lisofylline

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), DiaKine Therapeutics, Inc., Eastern Virginia Medical School

Conditions

HealthyType 1 DiabetesType 1 Diabetes Mellitus

Phase 1

Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes

CompletedNCT00896077

DiaKine Therapeutics, Inc.Healthy, Type 1 Diabetes

Start: 2009-05-31End: 2009-12-31Updated: 2014-07-29

Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus

TerminatedNCT01603121

Eastern Virginia Medical SchoolType 1 Diabetes Mellitus

Start: 2012-02-29End: 2013-05-31Updated: 2016-08-18

Phase 2

Strategies to Improve Islet Survival

CompletedNCT00464555

National Institute of Allergy and Infectious Diseases (NIAID)Type 1 Diabetes Mellitus

Start: 2006-12-31End: 2014-02-28Updated: 2016-04-26